Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis

BACKGROUND: Tofacitinib and other new treatments approved for use in psoriatic arthritis have only recently been included in psoriatic arthritis treatment guidelines, and studies evaluating the relative efficacy of available therapies are important to inform treatment decisions by healthcare profess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Ther Res Clin Exp
Main Authors: Gladman, Dafna D., Orbai, Ana-Maria, Gomez-Reino, Juan, Chang-Douglass, Stacey, Leoncini, Emanuele, Burton, Hannah E., Kanik, Keith S., Romero, Ana Belen, Cappelleri, Joseph C., Hsu, Ming-Ann
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7494680/
https://ncbi.nlm.nih.gov/pubmed/32983284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2020.100601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados